Rituximab chimeric anti-CD20 monoclonal antibody treatment for refractory hemolytic anemia in patients with lymphoproliferative disorders (Q73044362)
Jump to navigation
Jump to search
scientific article published on 01 February 2003
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rituximab chimeric anti-CD20 monoclonal antibody treatment for refractory hemolytic anemia in patients with lymphoproliferative disorders |
scientific article published on 01 February 2003 |
Statements
Rituximab chimeric anti-CD20 monoclonal antibody treatment for refractory hemolytic anemia in patients with lymphoproliferative disorders (English)
Giulio Trapè
Luana Fianchi
Marco Lai
Luca Laurenti
Roberta Piscitelli